Market Snapshot
  • U.S.
  • Europe
  • Asia
Ticker Volume Price Price Delta
DJIA 16,427.22 18.68 0.11%
S&P 500 1,869.29 4.44 0.24%
NASDAQ 4,109.54 14.03 0.34%
Ticker Volume Price Price Delta
STOXX 50 3,155.81 16.55 0.53%
FTSE 100 6,625.25 41.08 0.62%
DAX 9,409.71 91.89 0.99%
Ticker Volume Price Price Delta
NIKKEI 14,512.38 -3.89 -0.03%
TOPIX 1,171.40 -1.97 -0.17%
HANG SENG 22,760.24 64.23 0.28%

Medtech Industry Executives to Reveal Strategies for Gaining a Competitive Edge in Keynote Panel at EuroMedtech™ 2013



  Medtech Industry Executives to Reveal Strategies for Gaining a Competitive
  Edge in Keynote Panel at EuroMedtech™ 2013

EuroMedtech 2013

Business Wire

ZURICH & DUESSELDORF, Germany -- April 11, 2013

The fifth annual EuroMedtech™ partnering conference to be held May 7–8 in
Duesseldorf, Germany will feature executive panelists who will share insight
on business development models and strategies for success in the medtech
industry. As the leading partnering event for medical devices and technology,
the conference is a go-to event for leaders in medical technology, medtech
decision makers and investors.

The opening plenary is thematic of the event, and is entitled “Inside
innovation: How developments in financing, strategy and collaboration are
driving the medtech machine.” Plenary panelists, including Regina Hodits,
General Partner at Wellington Partners; Angelo de Rosa, Head of Strategy and
Business Development at Medtronic; Townsend Goddard, Senior Director, Business
Development and Strategy for Stryker; Mark Hitchman, Managing Director at
Toshiba Medical Systems UK; Cécile Vienney, CEO at HyPrevention; and Bill
Welch, Director at Abbott Ventures, Inc., will discuss new collaboration
models that help companies develop an edge in the medtech industry.

"Innovative products are not only changing the medical practice as in minimal
invasive surgeries, but are also demanding changes in business models," said
Hodits. “Market opportunities for medical devices and diagnostics - with the
potential to reduce overall financial burden for healthcare providers - are
here to stay; and venture financed companies have demonstrated that they can
successfully launch products and get them reimbursed in Europe. Based on these
sound fundamentals, we see a strong and attractive deal flow for healthcare
investors in Europe and believe there is potential for sustainable growth in
the sector. But we will all need to adapt in order to cope with ever higher
demands of an aging population and associated fierce cost pressure on the
health care systems. This will be one topic of the plenary.”

“If we hope to see improvements in healthcare in terms of market
accessibility, we are going to have to continue pursuing partnerships that
address successful implementation of medtech solutions,” said Hitchman.
“Product and technological innovation is important, but the industry will be
driven by the business strategies that allow us to attract investors and key
partners, while maintaining a competitive edge.”

“2012 was a big year for medtech mergers and acquisitions, and we are also
still seeing great opportunities for medtech companies in emerging markets, in
part due to aging populations’ demand for implantable devices,” said Vienny.
“Pricing pressures and other myriad challenges still exist, but the improving
economic outlook combined with creative business models arising from leaner
times have created partnership opportunities that will shape medtech going
forward.”

EuroMedtech is Europe’s leading medical technology partnering conference
providing collaboration opportunities to medtech decision makers and
investors. Participants meet with numerous potential partners and discuss in-
and out-licensing, financing and other collaborative programs. EuroMedtech
2013 will again feature the popular Next Generation Presentation track for
young entrepreneurial companies and the Company Presentation track for
innovative medtech corporations.

“A group of innovative medtech companies from West Sweden will be represented
at EuroMedtech 2013,” said Iris Öhrn, from Business Region Gothenburg. “The
growth of the medical device and therapeutics industry in Sweden and northern
European countries is strong, and our companies are looking for new business
alliances and partnerships for bringing their novel products to market and
successfully growing their existence business.”

Hosted by EBD Group, the leading partnering firm for the global life science
industry,  EuroMedtech caters to companies involved in all parts of the
advanced medical technology industry, from those serving mainline therapeutic
categories such as drug delivery and augmented intervention in medicine,
through diagnostics, imaging and eHealth to those involved in platform
technologies such as micro and nanotechnological tools and implantable
devices.

Applications to present can be submitted online at
http://www.ebdgroup.com/emt/presenters/index.php.

Registration information for EuroMedtech can be found online at
http://www.ebdgroup.com/emt/registration/index.php .

In 2012, the conference hosted more than 300 delegates representing 205
companies from 22 countries who engaged in 755 one-to-one partnering meetings.

For more information, visit the EuroMedtech website: ebdgroup.com/emt .

Notes to Editors:

Entry to EuroMedtech 2013 is free to members of the press, including full
access to the partnering system, sessions, press conferences, workshops, and
pre-arranged partnering meetings. Visit the EuroMedtech conference website at
http://www.ebdgroup.com/emt/registration/press_reg.php for registration
details.

About EBD Group

EBD Group is the leading partnering firm for the global life science industry.
Since 1993, biotech, pharma and medical device companies have leveraged EBD
Group’s partnering conferences, technology and services to identify business
opportunities and develop strategic relationships essential to their success.

EBD Group’s conferences are run with the support of leading corporations and
international trade associations and include:

  * BIO-Europe® and BIO-Europe Spring®, Europe’s largest life science
    partnering conferences, supported by the Biotechnology Industry
    Organization (BIO)
  * BioPharm America™, the fastest growing partnering event in North America
  * Biotech Showcase™, a unique forum in San Francisco for presenting to
    investors and business development executives, co-produced with
    Demy-Colton Life Science Advisors
  * BioEquity Europe, the investor conference co-organized with BioCentury
    Publications and BIO
  * ChinaBio® Partnering Forum, the first dedicated biotech/pharma partnering
    conference in China, co-produced with ChinaBio® LLC
  * EuroMedtech™, EBD Group’s partnering event for the innovative medical
    technology industry
  * Partnering for Global Impact®, a new partnering conference providing an
    innovative forum to partner, identify and generate social and
    philanthropic investment and funding opportunities

EBD Group’s sophisticated web-based partnering service, partneringONE®, is
also used as the partnering engine at numerous third-party events around the
world, and partnering360® is the open online community of life science
dealmakers that enhances partnering experiences all year long.

Outside of the conference format, EBD Group’s consultants provide hands-on
assistance for firms seeking to in- or out-license products and technologies.

EBD Group has offices in the USA and Europe.

For more information please visit www.ebdgroup.com.

Photos/Multimedia Gallery Available:
http://www.businesswire.com/multimedia/home/20130411006083/en/

Multimedia
Available:http://www.businesswire.com/cgi-bin/mmg.cgi?eid=50608113&lang=en

Contact:

EBD Group
Erin Righetti, +1-760-930-0500
erighetti@ebdgroup.com
Sponsored Links
Advertisement
Advertisements
Sponsored Links
Advertisement